EUVIMEDEUVIMED entdecken
Open Access

Hyperammonemia induces programmed liver cell death

Annarein J C Kerbert iD, Cornelius Engelmann, Abeba Habtesion iD, Pavitra Kumar iD, Mohsin Hassan iD, Tingting Qi iD, Ines Volkert iD, Tobias Otto, Andrew Hall, Varun U Khetan iD, Steven Olde Damink iD, Ferran Aguilar iD und 12 weitere

Science Advances · 07.03.2025 · 11 (10)

DOI: 10.1126/sciadv.ado1648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 07.03.2025. Verfasst von Annarein J C Kerbert und 23 weiteren Autor:innen. Beteiligte Einrichtung: Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK. Hauptthemen laut MEDLINE: Hyperammonemia, Liver. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperammonemia is common in liver cirrhosis and causally associated with hepatic encephalopathy development. Little is known about its hepatotoxic effects, which we aimed to characterize in this study. In a mouse model of chronic hyperammonemia without preexisting liver disease, we observed development of liver fibrogenesis and necroptotic cell death. Hyperammonemia also induced dysregulation of its main metabolic pathway, the urea cycle, as reflected by down-regulation of urea cycle enzyme protein expression and accumulation of its metabolites. Inhibition of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and its upstream inducer Toll-like receptor 4 (TLR4) protected against liver injury and further hyperammonemia. In clinically relevant rodent models of hyperammonemia (genetic ornithine transcarbamylase deficiency and bile duct ligation–induced cirrhosis), TLR4 inhibition reduced circulating ammonia. In conclusion, hyperammonemia induces liver fibrogenesis and RIPK1-mediated cell death, which is associated with urea cycle dysfunction. Inhibition of RIPK1 and TLR4 protects against hyperammonemia-induced liver injury and are potential therapeutic targets for hyperammonemia and chronic liver disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperammonemiaLiverAnimalsMiceToll-Like Receptor 4Disease Models, AnimalReceptor-Interacting Protein Serine-Threonine KinasesLiver CirrhosisMaleUreaAmmoniaMice, Inbred C57BLCell Death

Substanzen

Toll-Like Receptor 4Receptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouseUreaAmmoniaTlr4 protein, mouse

Autor:innen und Institutionen

  • Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
  • Department of Gastroenterology & Hepatology, Leiden University Medical Center, Leiden, Netherlands.
  • Medical Department, Division of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charite - Universitätsmedizin Berlin, Berlin, Germany.
  • Department of CardioMetabolic Disease Research, Boehringer Ingelheim, Biberach, Germany.
  • Department of Hepatology Unit and Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.

ORCID-Profile: Annarein J C Kerbert, Abeba Habtesion, Pavitra Kumar, Mohsin Hassan, Tingting Qi, Ines Volkert, Varun U Khetan, Steven Olde Damink, Ferran Aguilar, Joan Clària, Richard Moreau, Vicente Arroyo, Gautam Mehta, Florence Castelli, François Fenaille, Fausto Andreola, Rajiv Jalan

Zitieren

APA

Kerbert, A. J. C., Engelmann, C., Habtesion, A., Kumar, P., Hassan, M., Qi, T., Volkert, I., Otto, T., Hall, A., Khetan, V. U., Olde Damink, S., Aguilar, F., Chollet, C., Brunet, L., Clària, J., Moreau, R., Arroyo, V., Coenraad, M. J., Mehta, G., …, & Jalan, R. (2025). Hyperammonemia induces programmed liver cell death. Science Advances, 11(10). https://doi.org/10.1126/sciadv.ado1648

Vancouver

Kerbert AJC, Engelmann C, Habtesion A, Kumar P, Hassan M, Qi T, et al. Hyperammonemia induces programmed liver cell death. Science Advances. 2025;11(10). doi:10.1126/sciadv.ado1648

BibTeX
@article{Kerbert2025,
  author = {Kerbert, Annarein J C and Engelmann, Cornelius and Habtesion, Abeba and Kumar, Pavitra and Hassan, Mohsin and Qi, Tingting and Volkert, Ines and Otto, Tobias and Hall, Andrew and Khetan, Varun U and Olde Damink, Steven and Aguilar, Ferran and Chollet, Céline and Brunet, Ludovic and Clària, Joan and Moreau, Richard and Arroyo, Vicente and Coenraad, Minneke J and Mehta, Gautam and Castelli, Florence and Trautwein, Christian and Fenaille, François and Andreola, Fausto and Jalan, Rajiv},
  title = {Hyperammonemia induces programmed liver cell death},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {10},
  doi = {10.1126/sciadv.ado1648}
}
Kostenlos starten →